FDA Investigator Roberta W Cunningham
Roberta W Cunningham has conducted inspections on 150 sites in 1 countries as of 08 Jul 2009. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
150
Last Inspection Date:
08 Jul 2009
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Roberta W Cunningham:
Adam J Taylor,
Alicia M Mozzachio,
Amanda B Athey,
Amanda Dinaro,
Amanda S Zorn,
Amy Kim,
Ana L Kewes,
Andrew A Leboeuf,
Anna Flynn,
Anthony F Lorenzo,
Anthony R Ronga,
Ashley L Reiber,
Audrey Dela Cruz,
Brandon L Mariner,
Brentley S Collins,
Brian D Nicholson,
Brian P Emanuel,
Bruce H Mccullough,
Burnell M Henry,
Carl A Huffman, III,
Carla R Hinz,
Carrie Ann Plucinski,
CDR Sean T Creighton,
Chad E Schmear,
Chiang Syin, PhD,
Christina A Miller,
Christopher D Leach,
Clotia Cabbey Mensah,
Creighton T Tuzon,
Daniel C Kearns,
Daniel Kearns,
Dariusz Galezowski,
Darla J Christopher,
Darrell E Luedtke,
David J Gasparovich,
David Perkins,
Davyd Dfytsyk Kravets,
Debra I Love,
Debra Lboyd Seale,
Decarlos A Gomez,
Denarvis C Mendenhall,
Denise L Burosh,
Dolores Harper,
Doretha M Tonkins,
Dr. Gang Wang, PhD,
Dr. Guang Gao, PhD,
Dr. Mark J Seaton, PhD,
Edwardstine J Reese,
Elliot P Cowam, PhD,
Elyshia Q Danaher,
Emily S Mcgann,
Eric M Mueller, PharmD,
Eric S Pittman,
Eric T Huebler,
Erin M Mcdowell,
Esther A Ofori,
Gabryelle J Solverud,
Gene D Arcy,
Gregory R Dill,
Helen B Ricalde,
Humera T Khan,
Jacqueline Mdiaz Albertini,
James P Duggan,
James W Plucinski,
Jan B Welch,
Janae D Price,
Jason F Chancey,
Jayne E Holcomb,
Jeanne J Chiu,
Jeanne J Thai,
Jeanne M Morris,
Jennifer C Adams,
Jennifer C Johnson,
Jesse A Vazquez,
Joan A Loreng,
John A Iwen,
John P Brooks,
Joseph A Morkunas,
Joseph D Cooper,
Joshua M Adams,
Julie D Bringger,
Karen Emasley Joseph,
Kathleen B Swat,
Kathleen M Adams,
Kathleen S Tormey,
Kelly D Moore,
Kenneth L Smalls,
Kimberly Lewandowski Walker,
Kujtim Sadiku,
Kyran R Gibson,
Laiza V Garcia,
Lakisha M Williams,
Lana K Waselewski,
Latoya A Griffith,
Lauren A Crivellone,
Laurie A Haxel,
LCDR Ismael Olvera, IV,
Lee Terry Moore,
Lequita M Mayhew,
Lewis K Antwi,
Lisa Hayka,
Lisa Hornback,
Lorelei S Jarrell,
Maksim A Levenchuk,
Marc A Jackson, Jr,
Margaret Torres Vazquez,
Mark E Frank,
Mark I Kaspar,
Martha T Olone,
Matthew J Gretkierewicz,
Matthew J Sienko,
Maureen C Melvin,
Michael D Robinson,
Michele L Glendenning,
Michelle J Glembin,
Natasha R Johnson,
Nicholas F Lyons,
Nicholas Z Lu,
Nicole C Victoria, PhD,
Nicole J Clausen,
Nicole K Trudel,
Nicole S Williams,
Norman Wong,
Omotunde O Osunsanmi,
Pablo Alcantara,
Paola S Barnett,
Patricia A Mcilroy,
Paul M Chefor,
Phung Thien Nguyen,
Prabhu P Raju,
Rachel T Evans,
Rafael Padilla,
Robert L Stevenson,
Rose Ashley,
Rosemary Wood Sexton,
Russell K Riley,
Samuel W Labinjo,
Sarah B Tanksley,
Sarah Forney,
Shana L Williams,
Sherea L Dillon,
Simone E Pitts,
Stephen D Eich,
Sullan,
Susan A Zullo, PhD,
Susan D Yuscius,
Susan M Jackson,
Susan M North,
Susan P Bruederle,
Susan W Ciani,
Tamara Brey,
Tamara M Qtami,
Tara C Alcazar,
That Q Dang,
Theressa B Smith,
Thomas J Arista,
Thomas W Nojek,
Tiki J Dixon,
Todd M Stankewicz,
Tong Zhou,
Travis S Bradley,
Uruaku A Obasi,
William F Lagud, Jr,
William G Nelson,
William R Weissinger,
Yvonne E Lozano,
Zoey A Trombley
Roberta W Cunningham's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2008 | FDA 483 | Experimur, A Frontage Company - Form 483, 2008-03-13 |
| April, 2000 | EIR | Cardinal Health 200, LLC - EIR, 2000-04-07 |
| September, 2001 | FDA 483 Response | Baxter Healthcare Corporation - Form 483R, 2001-08-28 |
| September, 2001 | EIR | Baxter Healthcare Corporation - EIR, 2001-08-17 |
| June, 2003 | EIR | Abbott Laboratories - EIR, 2003-07-07 |
| September, 2001 | EIR | Baxter Healthcare Corporation - EIR, 2001-09-07 |
| September, 2001 | FDA 483 | Baxter Healthcare Corporation - Form 483, 2001-08-17 |
| March, 2000 | EIR | Stradis Healthcare - EIR, 2000-03-27 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more